Literature DB >> 20425509

Lyme disease: a review.

Adriana R Marques1.   

Abstract

Lyme disease is the most common vector-borne illness in the United States and is also endemic in Europe and Asia. It is caused by the spirochete Borrelia burgdorferi and transmitted by the bite of the Ixodes (deer) tick. It occurs most frequently during spring and summer and may involve the skin, nervous system, heart, and joints. This article reviews the pathogenesis, epidemiology, clinical manifestations, diagnosis, treatment, and prevention of Lyme disease.

Entities:  

Mesh：

Year:  2010        PMID： 20425509     DOI： 10.1007/s11882-009-0077-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.919


  65 in total

Review 1.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

2.  Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease.

Authors:  B Hemmer; B Gran; Y Zhao; A Marques; J Pascal; A Tzou; T Kondo; I Cortese; B Bielekova; S E Straus; H F McFarland; R Houghten; R Simon; C Pinilla; R Martin
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

3.  Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis.

Authors:  J J Nocton; B J Bloom; B J Rutledge; D H Persing; E L Logigian; C H Schmid; A C Steere
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

4.  Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans.

Authors:  Anamarija Zore; Eva Ruzić-Sabljić; Vera Maraspin; Joze Cimperman; Stanka Lotric-Furlan; Andreja Pikelj; Tomaz Jurca; Mateja Logar; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2002-07-31       Impact factor: 1.704

5.  Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.

Authors:  F T Liang; A C Steere; A R Marques; B J Johnson; J N Miller; M T Philipp
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice.

Authors:  Jennifer C Miller; Ying Ma; Jiantao Bian; Kathleen C F Sheehan; James F Zachary; John H Weis; Robert D Schreiber; Janis J Weis
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease.

Authors:  Gary P Wormser; Dionysios Liveris; Klára Hanincová; Dustin Brisson; Sara Ludin; Vincent J Stracuzzi; Monica E Embers; Mario T Philipp; Andrew Levin; Maria Aguero-Rosenfeld; Ira Schwartz
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

Review 8.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2008-09       Impact factor: 5.982

9.  Comparison of PCR methods and culture for the detection of Borrelia spp. in patients with erythema migrans.

Authors:  T Cerar; E Ruzić-Sabljić; U Glinsek; A Zore; F Strle
Journal:  Clin Microbiol Infect       Date:  2008-07       Impact factor: 8.067

10.  Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection.

Authors:  Loïc Coutte; Douglas J Botkin; Lihui Gao; Steven J Norris
Journal:  PLoS Pathog       Date:  2009-02-13       Impact factor: 6.823
View more
  29 in total

1.  Borrelia burgdorferi Infections in the United States.

Authors:  Warren R Heymann; Dana L Ellis
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

2.  Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease.

Authors:  Melanie Uhde; Mary Ajamian; Xueting Li; Gary P Wormser; Adriana Marques; Armin Alaedini
Journal:  Clin Infect Dis       Date:  2016-09-01       Impact factor: 9.079

3.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

4.  Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice.

Authors:  Luciana Meirelles Richer; Miguel Aroso; Tania Contente-Cuomo; Larisa Ivanova; Maria Gomes-Solecki
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

5.  Bacterial heterogeneity is a requirement for host superinfection by the Lyme disease spirochete.

Authors:  Artem S Rogovskyy; Troy Bankhead
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

6.  Phosphoenolpyruvate Phosphotransferase System Components Modulate Gene Transcription and Virulence of Borrelia burgdorferi.

Authors:  Bijay K Khajanchi; Evelyn Odeh; Lihui Gao; Mary B Jacobs; Mario T Philipp; Tao Lin; Steven J Norris
Journal:  Infect Immun       Date:  2015-12-28       Impact factor: 3.441

7.  Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.

Authors:  Elzbieta Jacek; Kevin S Tang; Lars Komorowski; Mary Ajamian; Christian Probst; Brian Stevenson; Gary P Wormser; Adriana R Marques; Armin Alaedini
Journal:  J Immunol       Date:  2015-12-30       Impact factor: 5.422

8.  Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.

Authors:  Abhishek Chandra; Gary P Wormser; Adriana R Marques; Norman Latov; Armin Alaedini
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

9.  Seroprevalence of equine granulocytic anaplasmosis and lyme borreliosis in Canada as determined by a point-of-care enzyme-linked immunosorbent assay (ELISA).

Authors:  Gili Schvartz; Tasha Epp; Hilary J Burgess; Neil B Chilton; David L Pearl; Katharina L Lohmann
Journal:  Can Vet J       Date:  2015-06       Impact factor: 1.008

10.  Cerebrospinal fluid proteome of patients with acute Lyme disease.

Authors:  Thomas E Angel; Jon M Jacobs; Robert P Smith; Mark S Pasternack; Susan Elias; Marina A Gritsenko; Anil Shukla; Edward C Gilmore; Carol McCarthy; David G Camp; Richard D Smith; H Shaw Warren
Journal:  J Proteome Res       Date:  2012-08-31       Impact factor: 4.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.